Condition: Presbyopia · Sponsor: Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Ltd.
A multicenter, randomized, double-Blind, crossover, placebo-controlled Phase II clinical Study to evaluate the efficacy and safety of BRIMOCHOL PF and CARBACHOL PF in the treatment of Chinese patients with presbyopia.
This description comes directly from the study's public registry record.
Peiqiu Gu · 0577-88075582 · EYE_ec@126.com
Xiaochen Wang
Always discuss trial participation with your own doctor first.
| Optometry Hospital of Wenzhou Medical University | Wenzhou, Zhejiang, China | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT06948357